Ashok Kumar Balaraman
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems 4
- Advanced Drug Delivery Systems 3
-
- Medicinal Plants and Neuroprotection 2
-
- Natural Antidiabetic Agents Studies 4
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
-
- Circular RNAs in diseases 4
-
- Pharmacological Effects of Natural Compounds 2
- Co-authors
- A. PuratchikodySam T. MathewJagadish SinghTapan Kumar MaityHaja Nazeer AhamedAsis BalaM. Arockia BabuPallab Kanti Haldar
- Partner nations
- IndiaMalaysiaSaudi Arabia
In The Last Decade
Ashok Kumar Balaraman
29 papers receiving 235 citations
Peers
Comparison fields: 5 of 72
- Pharmaceutical Science 88
- Complementary and alternative medicine 32
- Biochemistry 19
- Endocrinology, Diabetes and Metabolism 49
- Periodontics 13
Countries citing papers authored by Ashok Kumar Balaraman
This map shows the geographic impact of Ashok Kumar Balaraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok Kumar Balaraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok Kumar Balaraman more than expected).
Fields of papers citing papers by Ashok Kumar Balaraman
This network shows the impact of papers produced by Ashok Kumar Balaraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok Kumar Balaraman. The network helps show where Ashok Kumar Balaraman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ashok Kumar Balaraman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 3 | |
| 14 | 2020 | 0 | |
| 15 | A Review on Sira Vyadhana: An important Para-Surgical Procedure of Ayurveda | 2019 | 0 |
| 16 | Synergistic effect of Benalaxyl 8% and Mancozeb 65% WP in combating downy mildew of cucumber. | 2017 | 1 |
| 17 | 2015 | 32 | |
| 18 | Buccal Drug Delivery: Past, Present and Future – A Review | 2011 | 27 |
| 19 | Ethanol Extract of Melothria Maderaspatana Inhibits Glucose Absorption and Stimulates Insulin Secretion in Male C57BL/6 Mice | 2011 | 5 |
| 20 | 2011 | 33 |
About Ashok Kumar Balaraman
Ashok Kumar Balaraman is a scholar working on Complementary and alternative medicine, Pharmaceutical Science and Pharmacology, having authored 34 papers that have together received 265 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Drug Solubulity and Delivery Systems (4 papers), Natural Antidiabetic Agents Studies (4 papers), Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (3 papers), Advanced Drug Delivery Systems (3 papers), Medicinal Plants and Neuroprotection (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Pharmaceutical Science (88 citations), Complementary and alternative medicine (32 citations) and Biochemistry (19 citations). Ashok Kumar Balaraman has collaborated with scholars based in India, Malaysia and Saudi Arabia. Frequent co-authors include A. Puratchikody, Sam T. Mathew, Jagadish Singh, Tapan Kumar Maity, Haja Nazeer Ahamed, Asis Bala, M. Arockia Babu, Pallab Kanti Haldar, Srinivas Mutalik and Anindya Bose. Their work appears in journals such as Saudi Pharmaceutical Journal, Genes, Inflammopharmacology, Biogerontology and Current Neuropharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.